Skip to main content
Clinical Trials/NCT04958005
NCT04958005CompletedNot Applicable

Evaluation of Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children With Early Childhood Caries.

Aydin Adnan Menderes University1 site in 1 country58 target enrollmentStarted: July 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
58
Locations
1
Primary Endpoint
IL-32

Study Overview

Brief Summary

This study aimed to evaluate the levels of interleukin 10, interleukin 6, interleukin 32 and tumor necrosis factor-alpha (TNF-α) in saliva of children with early childhood caries.

Detailed Description

Fifty six children ( 28 with early childhood caries and 28 without early childhood caries ; age range 3-6 years) will be recruited for the study. Probing pocket depth (PPD), gingival index (GI) and plaque index (PI) will be recorded and saliva samples will be collected. Interleukin-32, Interleukin-10, Interleukin-6 and TNF-α will be analyzed in saliva samples by ELISA.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
3 Years to 70 Months (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Children with untreated early chilhood caries
  • Age between 3 and 6 years

Exclusion Criteria

  • Having a systemic problem or mental retardation
  • Children with treated caries

Outcomes

Primary Outcomes

IL-32

Time Frame: Baseline

Interleukin- 32 level

IL-10

Time Frame: Baseline

Interleukin- 10 level

Secondary Outcomes

  • Tnf-Alpha(Baseline)
  • IL-6(Baseline)

Investigators

Sponsor
Aydin Adnan Menderes University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sultan KELES

Assoc.Prof.Dr.

Aydin Adnan Menderes University

Study Sites (1)

Loading locations...

Similar Trials